# Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT

> **NCT06598917** · PHASE2 · NOT_YET_RECRUITING · sponsor: **China Medical University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Locally Advanced Unresectable Esophageal Cancer

## Interventions

- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT06598917
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2026-10-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06598917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06598917, "Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06598917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
